StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker Trauma and Extremities by Quarter

Trauma and Extremities (Core Trauma, Upper Extremities / Shoulder & Foot/Ankle) — U.S. Sales Growth YoY (Reported / Constant Currency, %) (%)

QuarterlyAnnual

Stryker Trauma and Extremities: 4.5% in Q3 2026, down 8.7 pts from a year earlier.

Latest, Q3 2026
4.5%
Period ended Sep 30, 2026
Change on a year earlier
-8.7 pts
13.2% in Q3 2025
History
41 quarters
Since Q4 2015
Sources
41
Documents cited below

Where the Q3 2026 figure comes from

Reported in Stryker Form 8-K Supplemental Sales Schedules (100% USD; Reported = Constant Currency).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTrauma and Extremities (Core Trauma, Upper Extremities / Shoulder & Foot/Ankle) — U.S. Sales Growth YoY (Reported / Constant Currency, %) (%)Year on yearSource
Q3 2026Sep 30, 20264.5%-8.7 pts0000310764-26-000059|sykex991earningsq32026.htm ↗
Q2 2026Jun 30, 202612.5%-2.6 pts0000310764-26-000048|sykex991earningsq22026.htm ↗
Q1 2026Mar 31, 20267.6%-9.0 pts0000310764-26-000025|sykex991earningsq12026.htm ↗
Q4 2025Dec 31, 20258.5%-8.9 pts0000310764-26-000006|sykex991earningsq42025.htm ↗
Q3 2025Sep 30, 202513.2%+0.3 pts0000310764-25-000126|sykex991earningsq32025.htm ↗
Q2 2025Jun 30, 202515.1%+6.0 pts0000310764-25-000103|sykex991earningsq22025.htm ↗
Q1 2025Mar 31, 202516.6%+6.3 pts0000310764-25-000072|sykex991earningsq12025.htm ↗
Q4 2024Dec 31, 202417.4%+5.3 pts0000310764-25-000005|sykex991earningsq42024.htm ↗
Q3 2024Sep 30, 202412.9%+1.4 pts0000310764-24-000113|sykex991earningsq32024.htm ↗
Q2 2024Jun 30, 20249.1%-5.2 pts0000310764-24-000095|sykex991earningsq22024.htm ↗
Q1 2024Mar 31, 202410.3%-3.4 pts0000310764-24-000062|sykex991earningsq12024.htm ↗
Q4 2023Dec 31, 202312.1%+0.2 pts0000310764-24-000005|sykex991earningsq42023.htm ↗
Q3 2023Sep 30, 202311.5%+1.1 pts0000310764-23-000114|sykex991earningsq32023.htm ↗
Q2 2023Jun 30, 202314.3%+11.2 pts0000310764-23-000104|sykex991earningsq22023.htm ↗
Q1 2023Mar 31, 202313.7%+3.1 pts0000310764-23-000065|sykex991earningsq12023.htm ↗
Q4 2022Dec 31, 202211.9%-18.8 pts0000310764-23-000005|sykex991earningsq42022.htm ↗

Cite this data

StockData. (2026). Stryker Trauma and Extremities (%), quarterly Q4 2015–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-trauma-us-rep

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.